Photo generated from dailynews.ascopubs.org
Apr 6, 2024, 14:49
Chul Kim: Check out our article featured in ASCO Daily News
Amy Moore, Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation, recently shared a post by Chul Kim, Thoracic Medical Oncologist at Georgetown University, on X, adding:
“As targeted therapy moves to the early-stage setting in lung cancer, it is imperative: first to improve early detection to find those who will benefit and second to conduct comprehensive biomarker testing to match people to the appropriate treatment.”
Quoting Chul Kim’s post:
“Check out our article featured in ASCO Daily News ‘Improving Outcomes for Early-Stage NSCLC Using Targeted Therapy.’
A big shout-out to Dr. Vanya Aggarwal, a second-year fellow at Georgetown Lombardi, for her great work”
Read further.
Sources: Amy Moore/X and Chul Kim/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 15, 2024, 21:37
Nov 15, 2024, 21:26
Nov 15, 2024, 21:09
Nov 15, 2024, 21:05
Nov 15, 2024, 21:03
Nov 15, 2024, 21:02
Nov 15, 2024, 20:28
Nov 15, 2024, 19:31
Nov 15, 2024, 17:47
Nov 15, 2024, 17:45